This study demonstrates the clinical value of circulating tumor cells in predicting progression-free and overall survival rates. 该研究证明了循环肿瘤细胞在预测非进展性肿瘤患者生存率和总体生存率上的临床价值。
The five-gene signature was an independent predictor of relapse-free and overall survival. 这五个基因是对无复发和总生存率的独立预测指标。
Overall survival and progression-free survival also did not differ in the two groups, the researchers note. 研究人员提到,在两组中总生存期和无进展生存也没有差异。
Overall survival ( OS ) and quality of life were secondary endpoints. 次级预期目标是提高总存活数(OS)和生活质量。
Overall survival and safety are among the secondary endpoints that will be assessed in the trial. 总生存率及安全性被包括在研究的次要终点中进行评估。